OVERVIEW

Examining the Latest Evidence for AMD Treatment is organized by Prime Education LLC.

Dates:
Release Date: December 6, 2019
Expiration Date: December 6, 2020

Accreditation:
• 1.0 CME/CE for Physicians (ACCME)
• 1.0 CPE for Pharmacists (ACPE + NABP)
• 1.0 CNE for Nurses (ANCC)

Activity Overview:
In this webcast, an expert retina specialist and managed care pharmacist uncover the latest clinical data in the treatment of age-related macular degeneration (AMD). They outline the framework and practical considerations for managed care pharmacists for appropriate patient selection and therapy utilization with anti-VEGF agents in AMD.

Viewers will also discover:
• What anti-VEGF therapies are in the pipeline for the management of patients with AMD
• The latest comparative efficacy and safety evidence on new and emerging therapies for AMD
• Which novel dosing strategies have proven effective and provide new options for patients with AMD
• How emerging evidence will impact decision-making for the retina specialist and the managed care pharmacist

Learning Objectives:
• Align managed care and specialty pharmacy strategies with AMD guidelines and the latest clinical data on safety and efficacy of new and emerging anti-VEGF agents
• Apply recent research on the comparative effectiveness of anti-VEGF treatments to therapy selection for patients with AMD
• Develop managed care and specialty pharmacy frameworks that account for evolving therapeutic mechanisms and dosing regimens in AMD

Additional details will be posted as soon as information is available.